Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niti Goel

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Pharmacology Research & Perspectives|February 9, 2018
Pharmacokinetic equivalence, comparable safety, and immunogenicity of an adalimumab biosimilar product (M923) to Humira in healthy subjectsJan Hillson, Tim Mant, Molly Rosano, et al.
The Journal of Rheumatology|October 17, 2016
Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working GroupLouise Klokker, Peter Tugwell, Daniel E Furst, et al.
The Journal of Rheumatology|April 16, 2021
Test-retest Reliability for HAQ-DI and SF-36 PF for the Measurement of Physical Function in Psoriatic ArthritisYing Ying Leung, William Tillett, Pil Hojgaard, et al.
The Journal of Rheumatology|February 16, 2022
Plain Radiographic Instruments for Structural Damage in Peripheral Joints in Psoriatic Arthritis: A Report From the GRAPPA-OMERACT Working GroupAnna Antony, Richard Holland, Ashish J Mathew, et al.
Seminars in Arthritis and Rheumatism|March 10, 2024
Embracing unity at OMERACT: Valuing equity, promoting diversity, fostering inclusivityLara J Maxwell, Grace C Wright, Grayson Schultz, et al.
The Journal of Rheumatology|February 17, 2015
Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12Lilian H van Tuyl, Martina Sadlonova, Bev Davis, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 UpdatesYing Ying Leung, William Tillett, Ana-Maria Orbai, et al.
Seminars in Arthritis and Rheumatism|August 27, 2021
Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiativeSebastian Bruera, Loreto Carmona, Maria A Lopez-Olivo, et al.
Seminars in Arthritis and Rheumatism|February 18, 2021
Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiativeAnna Antony, Richard Holland, Maria-Antonietta D'Agostino, et al.
The Journal of Rheumatology|July 7, 2023
Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working GroupYing-Ying Leung, William Tillett, Maarten de Wit, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Pharmacology Research & Perspectives|February 9, 2018
Pharmacokinetic equivalence, comparable safety, and immunogenicity of an adalimumab biosimilar product (M923) to Humira in healthy subjectsJan Hillson, Tim Mant, Molly Rosano, et al.
The Journal of Rheumatology|October 17, 2016
Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working GroupLouise Klokker, Peter Tugwell, Daniel E Furst, et al.
The Journal of Rheumatology|April 16, 2021
Test-retest Reliability for HAQ-DI and SF-36 PF for the Measurement of Physical Function in Psoriatic ArthritisYing Ying Leung, William Tillett, Pil Hojgaard, et al.
The Journal of Rheumatology|February 16, 2022
Plain Radiographic Instruments for Structural Damage in Peripheral Joints in Psoriatic Arthritis: A Report From the GRAPPA-OMERACT Working GroupAnna Antony, Richard Holland, Ashish J Mathew, et al.
Seminars in Arthritis and Rheumatism|March 10, 2024
Embracing unity at OMERACT: Valuing equity, promoting diversity, fostering inclusivityLara J Maxwell, Grace C Wright, Grayson Schultz, et al.
The Journal of Rheumatology|February 17, 2015
Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12Lilian H van Tuyl, Martina Sadlonova, Bev Davis, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 UpdatesYing Ying Leung, William Tillett, Ana-Maria Orbai, et al.
Seminars in Arthritis and Rheumatism|August 27, 2021
Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiativeSebastian Bruera, Loreto Carmona, Maria A Lopez-Olivo, et al.
Seminars in Arthritis and Rheumatism|February 18, 2021
Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiativeAnna Antony, Richard Holland, Maria-Antonietta D'Agostino, et al.
The Journal of Rheumatology|July 7, 2023
Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working GroupYing-Ying Leung, William Tillett, Maarten de Wit, et al.
Pageof 10